The alteration of lipid metabolism in cancer cells often includes enhanced fatty acid β-oxidation as a source of NADH, FADH2, and NADPH (Hu et al., 2022), while relying in cytosolic FAS for lipid generation (Röhrig and Schulze, 2016). The gene discussed is FAS; the disease is cancer.